Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Immune-Mediated Inflammatory Diseases, Dyslipidemia, and Cardiovascular Risk: A Complex Interplay

Arteriosclerosis Thrombosis and Vascular Biology(2024)10.1161/atvbaha.124.319983Source: DataRank Database

Immune-Mediated Inflammatory Diseases, Dyslipidemia, and Cardiovascular Risk: A Complex Interplay is a research paper published in Arteriosclerosis Thrombosis and Vascular Biology (2024). On theSindex it has a DataRank of 0. It has been cited 46 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access46 citations

Download PDF

Cite:

Linked data & code

nct

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (3 grants)Impact (FWCI 15.52)OA: greenTopics (42)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (2)

Michael D Shapiro ORCID,Michael J. Wilkinson ORCID

Live enrichment

PubMed:39479765 PMC:PMC11602385 OpenAlex:https://openalex.org/W4403953234

NIDDK NIH HHS

Grant: L30 DK130123

NCATS NIH HHS

Grant: KL2 TR001444

NIDDK NIH HHS

Grant: R01 DK118278

FWCI

15.52

Citation Percentile

1.0%

Citation Trend

2024

2025

2026

green

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC11602385/pdf/nihms-2030764.pdf

publisherhttps://www.ahajournals.org/doi/full/10.1161/ATVBAHA.124.319983

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC11602385/

journalhttps://doi.org/10.1161/atvbaha.124.319983

Fields of Study

Systemic Lupus Erythematosus ResearchAtherosclerosis and Cardiovascular DiseasesLipoproteins and Cardiovascular HealthHumansDyslipidemiasCardiovascular DiseasesHeart Disease Risk FactorsInflammationRisk AssessmentAnimalsAutoimmune DiseasesAnti-Inflammatory AgentsHypolipidemic AgentsHydroxymethylglutaryl-CoA Reductase Inhibitors

MeSH Terms

Heart Disease Risk FactorsAnimalsAnti-Inflammatory AgentsHypolipidemic AgentsAutoimmune DiseasesCardiovascular DiseasesHumansInflammationRisk AssessmentHydroxymethylglutaryl-CoA Reductase InhibitorsDyslipidemias

Keywords

MedicineImmunologyRheumatoid arthritisDyslipidemiaImmune systemInflammationDiseaseSystemic lupus erythematosusAutoimmune diseasePopulationSystemic inflammationInternal medicineAntibodyAtherosclerosisCardiovascular diseasesAutoimmune diseasesDyslipidemias

Sustainable Development Goals

SDG 0: Good health and well-being